On Monday, Pfizer revealed three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5.
Sources said Pfizer hopes to provide the data to U.S. regulators later this week in a step toward letting the littlest kids get the shots.
The news is an answer to the call of parents desperate to vaccinate their babies, toddlers, and preschoolers, especially as COVID-19 cases once again are rising.
According to reports, the 18 million tots under 5 are the only group in the U.S. not yet eligible for COVID-19 vaccination.
Earlier, it was reported that the Food and Drug Administration has begun evaluating data from rival Moderna, which hopes to start offering two kid-sized shots by summer.
The FDA is expected to review Moderna’s data on the youngest age group and its study of teens and elementary-age children.
It was reported that other countries already had expanded Moderna’s shot to kids as young as 6.